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Abstract 
Purpose/objectives: To describe the experiences of stigma and coping strategies among patients with lung cancer 
in China.
Research approach: Qualitative.
Setting: The oncology department at Liaocheng Peoples Hospital.
Participants: A purposive sample of 17 patients experiencing stigma related to lung cancer voluntarily participated 
in data collection.
Methodologic approach: Individual, semistructured qualitative interviews were chosen. Participants completed 
about a 30-min focused interview. Exploratory qualitative approach guided data analysis.
Findings: Three main thematic elements emerged from the interview data:(1) sources of stigma, such as smoking, 
decreased ability to work, difficulties caring for self and family, damage to self-image, and cough and expectoration; 
(2) experiences of stigma, including feelings of stigma, remorse, loss of dignity, uselessness, social isolation, perceived 
exclusion, rejection, and discrimination; and (3) coping strategies, such as concealing the fact of sickness, reducing 
social activities, seeking medical assistance, adhering to treatment, and disclosing dissatisfaction.
Conclusions: Our results indicate the presence of perceived stigma among patients with lung cancer. Future work 
should address the stigma associated with lung cancer and its related factors.
Interpretation: As point-of-care providers, staff nurses are well positioned to develop effective interventions to help 
patients deal with stigma and to accomplish the goal of providing holistic nursing care.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Lung cancer is the most frequent cause of cancer death 
among men and women worldwide (Juan et  al. 2015; 
Wille et al. 2016). In 2008 in China, lung cancer replaced 
liver cancer as the leading cause of death among cancer 
patients and the Chinese lung cancer registry reported 
that lung cancer accounted for 22.7 % of all malignancies 
(She et al. 2013).
Advances in research along with newer treatment 
protocols have increased life expectancy (Huang et  al. 
1993). With increased life expectancy, patients and their 
families are having to cope with the challenges of liv-
ing with a disease that is often perceived by others, and 
even the patients themselves, to have been caused by a 
“bad” behavior–smoking. While recognizing the deadly 
role that smoking causes in lung cancer development, 
emphasizing an individual’s smoking history (or non-
smoking history)underpins blame and is not effective in 
reducing or coping with the disease’s associated mark of 
disgrace or “stigma” of smoking (Chambers et al. 2012). 
As smoking has become more socially unacceptable there 
has been a significant increase in negative mood among 
smokers, who are experiencing shame, blame, and stigma 
(Stuber et al. 2009). Stigma itself may be “stacked” when 
the negative event (having lung cancer) is linked with 
the stigma of smoking, with increased rejection, exclu-
sion, alienation, or discrimination by others as a result of 
a disease and its perceived cause (Liu and Wang 2012). 
Lung cancer patients experience the perception of being 
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blamed for smoking as the “stigma”, in a very different 
context than personally believing smoking caused their 
lung cancer. A growing body of evidence suggests that 
lung cancer stigma (LCS) not only affects the psycho-
logical health, but also the physical health of lung cancer 
patients (Chapple et al. 2004; Cataldo et al. 2012).
In 2014, A Chinese version of the Cataldo Lung Can-
cer Stigma Scale (CLCSS-CV) was used to assess the 
stigma experienced by Chinese lung cancer patients, and 
researchers found that “lung cancer patients in China 
generally experience some form of social stigma as a 
result of their disease” (Yang et  al. 2014). Nonetheless, 
the nature and essence of the Chinese patient’s expe-
rience of coping with the “stigma” of lung cancer is not 
known. The purpose of this research was to describe the 
experience of Chinese patients in coping with the stigma 
of a lung cancer diagnosis. A qualitative approach was 
used to examine the subjective experience of Chinese 
patient’s coping with the stigma of a diagnosis of lung 
cancer. We were interested in the patient’s perception 
of the cause of their lung cancer and how others reacted 
to them. The research question guiding the study was 
“What is the lived experience of coping with the stigma 
of lung cancer in China?”
In recent years, stigma related to lung cancer has 
become a growing area of study for researchers (Hamann 
et  al. 2014; LoConte et  al. 2008; Chambers et  al. 2012). 
In 2004, Chapple and colleagues interviewed 45 patients 
with lung cancer and asked about their experiences fol-
lowing diagnosis (Chapple et  al. 2004). Their qualitative 
study indicated that patients with lung cancer experi-
enced stigma because the disease is directly attributable 
to the intensity of tobacco use. According to LoConte 
and colleagues (LoConte et al. 2008), and Lebel and col-
leagues (Lebel et  al. 2013), lung cancer patients had 
higher levels of perceived cancer-related stigma than 
patients with prostate, head, neck, or breast cancers. 
Conlon and colleagues, in a study of oncology social 
workers’ perceptions of lung cancer experience, reported 
that lung cancer patients have high rates of “stacked” 
stigma with respect to cigarette smoking (Conlon et  al. 
2010). The negative emotional phenomenon of stigma 
increases the burden on patients. In a study of 95 patients 
with stage II–IV non-small-cell lung cancer, Gonzalez 
and Jacobsen reported that perceived stigma and depres-
sion were positively correlated (r = 0.46, P < 0.001) (Gon-
zalez and Jacobsen 2012). Cataldo and colleagues also 
reported the presence of an inverse relationship between 
LCS and quality of life (r  =  0.65, P  <  0.001) (Cataldo 
et al. 2011). To better measure perceived stigma and its 
effects on patients with lung cancer, Cataldo and col-
leagues developed and evaluated the Cataldo Lung Can-
cer Stigma Scale (CLCSS) (Cataldo et al. 2011), a reliable 
and valid measure of health-related stigma for lung can-
cer patients. Each stigma item was measured using a 
four-point Likert-type scale ranging from 1 (strongly dis-
agree) to 4 (strongly agree). Ratings are summed to form 
a cumulative score. The 46 item CLCSS scale potential 
range of scores was 46–184 with a higher score meaning 
more stigma (Cataldo et al. 2012). A Chinese version of 
the CLCSS scale (CLCSS-CV) has been used to identify 
stigma in China. The CLCSS-CV includes 27 items and 
4 subscales. Each item was measured through a four-
point Likert scale ranging from 1 (strongly disagree) to 
4 (strongly agree), and two items were scored inversely. 
Higher scores indicate a stronger stigma perceived by 
patients. For the Chinese version, the score was the mean 
of all items answered (sum/# items answered). The aver-
age score on the CLCSS-CV obtained in testing was 
(2.68 ± 0.40). As tested by Yang and colleagues, the val-
ues for the CLCSS-CV from 2.29 to 2.68 indicate a low 
level of stigma; 2.69 to 3.08 indicate moderate stigma, 
and a score of >3.09 indicates a high level of stigma (Yang 
et  al. 2014). To purposely obtain a sample of patients 
for the current study, 2.29 as a cut-off score was used to 
identify patients who experienced “stigma”.
Although the measurement of perceived stigma has 
been well-studied using quantitative methodology 
(LoConte et  al. 2008; Chambers et  al. 2012; Yang et  al. 
2014; Hamann et  al. 2014), quantitative research by its 
very nature is constrained to studying a limited num-
ber of variables and may not capture the full experience 
of living with a disease. A related and independent phe-
nomenon involves coping with the stigma of lung cancer, 
including changes in identities, roles, family bonds, and 
patterns of behavior. Routine treatment of lung cancer 
is rigorous, complicated, and exhausting. Dealing with 
complex radiation and chemotherapy regimens as well as 
surgery in some cases can prove to be very stressful for 
patients and their family members. This stress is com-
pounded when the perceived stigma of having the disease 
results in isolation from others and disrupts daily life and 
social interactions (Yang et al. 2014). The patient’s lived 
experience of coping with stigma may be in areas not 
captured in quantitative research. There are few quali-
tative research studies on living with lung cancer that 
address the experience of living with the stigma of this 
extremely complex multivariate disease, and no studies 
were identified for the Chinese population.
In summary, there is a body of quantitative research 
documenting that stigma is experienced by lung cancer 
patients, including those living in China. Understand-
ing the experience of Chinese patients’ coping with 
the stigma has not been studied. Qualitative research 
approaches are best suited to describing the phenom-
enon of coping with the stigma of lung cancer. Helping 
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nurses to understand how patients live with the disease 
and cope with related stigma may change practice.
Methods
Participants and procedure
The study was an exploratory qualitative analysis using 
guided interviews. Although no USA formal Institutional 
Review Board was available, Taishan Medical Univer-
sity and Liaocheng Peoples’ hospital ethics committee 
approved the study (#201306).
Participants were recruited based on their first-hand 
experience with the phenomenon of interest (stigma) to 
allow for descriptions of the life experiences of coping 
with the stigma of lung cancer. Patients were eligible to 
take part in the study if they were age 20 years or older, 
diagnosed with lung cancer by pathological examina-
tion, aware of their diagnosis, identified stigma (at least 
2.29: possible range 1–4) on the modified Chinese ver-
sion of the Cataldo Lung Cancer Stigma Scale (CLCSS-
CV) (Cataldo et  al. 2011; Yang et  al. 2014), were awake 
and alert, were able to express their own opinions, native 
standard Chinese speakers, and they or their family 
members could provide informed consent.
A purposive sample of 17 patients experiencing stigma 
related to lung cancer voluntarily participated in data 
collection. Permission to do the study was also obtained 
from the hospital administrators and departments. Writ-
ten informed consent was obtained from 6 patients and 
for the other 11 patients who could not complete writ-
ten consent, an oral consent from the patient and a fam-
ily member was obtained. Ten (10) men and seven (7) 
women being treated in a tertiary hospital in Shandong 
Province in China were recruited for this study. They had 
a mean age of 58.3 years (range 29–80 years). Four of the 
participants (23.5  %) had completed elementary school, 
four (23.5 %) had completed junior high school, and nine 
(52.9 %) had completed senior or secondary high school. 
Three patients with stage II cancer, seven patients with 
stage III cancer and seven patients with stage IV partici-
pated. More details of the participant demographics are 
shown in Table 1.
Data generation and analysis process
The researcher and assistants had administered the 
CLCSS-CV to lung cancer patients and assisted patients 
having difficulty reading to complete the scale as part of 
a previous study (Yang et al. 2014). If “stigma” was identi-
fied, and other inclusion criteria were met, after obtain-
ing consent of the patients and family members present 
in the hospital setting as needed for oral consent, focused 
interviews were conducted with the patients.
The first author did all the interviews assisted by the 
head nurse of the tumor departments at Liaocheng 
Peoples Hospital. An interview guide (see Table  2) 
consisting of open-ended questions was used. Ques-
tions for the interview were generated in advance by 
the researchers and, although not piloted with patients, 
were reviewed by expert nurses familiar with the prob-
lem of cancer stigma to support content validity. The 
guide was used to elicit personal descriptions of the 
experience of coping with stigma in living with lung 
cancer. Sensitivity to issues of vulnerability and physi-
cal limitations for patients with lung cancer and their 
families required modification of data collection meth-
ods–exhaustive interviews were not possible. Although 
six questions were generated in advance, due to the 
breathlessness associated with the patient’s conditions, 
after the first interview, the interview guide was short-
ened to three questions (#3, #5, and # 6) that were used 
for “focused” 30 min interviews and any of the remain-
ing three questions were only used if time and the 
patient’s condition allowed. Interviews were conducted 
at the bedside, audio recorded and transcribed. Detailed 
field notes were kept as well. Thus adapting the quali-
tative process to the patient’s real-world limitation in 
breathing, we were able to capture the experience in the 
patient’s own words-staying true to the intent of quali-
tative research. The investigators met to read the tran-
scripts and discuss emerging themes. The interview 
questions were as follows: BOLD questions (#3, #5, and 
#6) are the three asked first and thus were most often 
used.
The data analysis process involved multiple steps. The 
interview transcripts were verified for accuracy and com-
pleteness by comparing them to the recordings, and then 
read repeatedly by the first author and discussed and 
reviewed with the other authors. Significant comments 
related to the patient’s experiences of stigma and coping 
with stigma were extracted, followed by description of 
the meanings. Identified themes then emerged from the 
aggregated meanings. Tables  3, 4 and 5 provide exam-
ples of significant statements that were responses to the 
questions, organized by the corresponding themes and 
sub-themes. Original words from the transcripts were 
examined to confirm each theme. The researchers then 
assimilated results, and formulated the description of 
experience of stigma and coping with stigma for Chinese 
patients hospitalized with lung cancer.
The rigor of the study (credibility/validity and dependa-
bility/reliability) was supported through confirmability and 
transferability (Cope 2014). Confirmability was achieved 
through the use of an audit trail and review of raw data by 
the other researchers. Transferability refers to the prob-
ability that the study findings have meaning to others in 
similar situations (Miyata and Kai 2006). The comparison 
of current findings to previous research is included.
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Findings
Three themes of stigma and coping strategies were 
derived from the experiences of the participants: (1) 
sources of stigma; (2) experiences of stigma; and (3) cop-
ing strategies.
These findings are presented below.
Theme 1: sources of stigma
Many patients experience stigma due to smoking, 
decreased ability to work, difficulties caring for self and 
Table 1 General demographic information for the 17 participants




Cancer stage Treatment Length of lung 
cancer diagnosis 
(months)










3 Female 66 Married Rural Elementary 
school
IV Surgery 12
4 Female 53 Married Urban Secondary 
school
IV Chemotherapy 15





6 Male 70 Married Urban Secondary 
school
IV Chemotherapy 9





8 Male 68 Married Rural Junior high 
school
III Surgery 14
9 Male 43 Married Urban Secondary 
school
II Chemotherapy 5
10 Male 68 Married Rural Elementary 
school
IV Chemotherapy 9















14 Female 48 Married Rural Elementary 
school
III Chemotherapy 11





16 Male 69 Married Urban Senior high 
school
III Chemotherapy 13





Table 2 Selected questions used in guided data collection
Focus questions
(1) What has it been like for you since you were diagnosed with lung cancer? What were the attitudes of others immediately following your diagnosis?
(2) When you experience negative emotions, how do you adjust? What factors have helped you to overcome the psychological distress?
(3) Have you encountered unfair treatment in your daily life since you were diagnosed with lung cancer? Please provide an example
(4) How do you feel when you suffer from discrimination, dislike, rejection, and alienation? Please use a few examples to illustrate your feelings
(5) How did your feelings about the stigma you have experienced affect your work, study, and life?
(6) When suffering from discrimination, dislike, rejection, and alienation, how do you respond?
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Table 3 Sources of stigma
Themes Findings and supporting quotes
1.1 Smoking Cigarette smoking represents a primary risk factor for lung cancer. More than 80 % of diagnoses occur in cur-
rent or former smokers. The participants often expressed regret at having smoked
Participant 2: “I started smoking at age 16. So far, I have smoked for 40 years. Now I have the disease and it feels that 
I am being punished! I have spent a lot of money in treating the disease, I feel very guilty. I think that if I had not 
smoked at that time, it would have been better”
Participant 3: “I have smoked for 40 years, and now I have the disease. It’s a punishment. If only I had not smoked at 
the beginning. I feel very guilty and much remorse.” Although approximately 80–90 % of all lung cancer cases 
are smoking related, some patients do not have a history of smoking (Gómez et al. 2007). However, partici-
pants reported that people around them believed that these patients had lung cancer because of smoking
Participant 11: “A few good friends came to see me last week. They told me lung cancer is related to smoking. They 
act as though it is my fault that I have lung cancer. However, I have never smoked. I felt quite upset”
1.2 Decreased ability to work Due to lung cancer, patients may find they have reduced physical abilities, meaning they are unable to work 
as hard as they did previously
Participant 15: “The company had planned to give me a promotion to general manager. The board of directors 
heard from someone that I got lung cancer, so my boss didn’t promote me. Ah, that’s because of the disease…”
1.3 Difficulties caring for self and family The participants reported being very weak after receiving treatment for their disease and needing care from 
their families after hospital discharge. Not only were they unable to care for themselves, but they were also 
unable to care for their families as they had previously. As a result, the participants reported developing 
feelings of shame and remorse
Participant 1: “It doesn’t matter how I have suffered. I am afraid that the disease will cause problems for my grand-
son. I haven’t been able to take care of my grandson”
Participant 8: “Now I cannot afford any help for my children. Instead, I trouble them a lot…I felt even guiltier”
Participant 9: “I cannot even help my children”
1.4 Damage to self-image Lung cancer itself and chemotherapy for treatment with related side-effects can cause hair loss, weakness, 
and disfigurement, leading to a negative self-image. These changes were identified as a cause of stigma
Participant 3: “After my first chemotherapy treatment, a lot of hair fell out. When I was out shopping, others asked 
me ‘What’s wrong with your hair?’ I felt they whispered about me even when I didn’t notice them talking”
Participant 4: “My hair has fallen out; my legs were probably invaded by metastatic disease. Now I walk with a limp, 
not a good image”
Participant 9: “Now my hair has fallen out and I always vomit because of chemotherapy. Now I have a poor quality 
of life and I have no dignity”
Participant 14: “I have a bad cough. As soon as I cough, my family will frown. So I usually try to cough as little as I 
can possibly help”
Participant 17: “The cancer cells spread to the breast, so the side of the breast was removed; I feel so ashamed”
Table 4 Experiences of stigma
Themes Findings and supporting quotes
1.1 Perceived discrimination In the interviews, the patients talked about their experiences of being rejected and discriminated against by their 
families, friends, other patients, colleagues, supervisors and neighbors
Participant 1: “When the cleaner gave back my patient robes, she wore gloves and a face mask, and washed her hands 
with soap several times. This is discriminating against and detesting me, isn’t it?”
Participant 2: “Because my kids are studying abroad, the company arranged for a colleague to take care of me. But I feel 
he is afraid of me and always tries to avoid me. Once I saw him secretly asking the head nurse whether the disease was 
infectious”
Participant 10: “The patient sharing the room with me had gastric carcinoma. I was coughing. He thought my disease 
was contagious and tried to avoid me. Last time, his granddaughter came to see him. He did not let her enter the room. 
Later, I underwent chemotherapy with the side effects of nausea and vomiting. He felt uncomfortable and asked to be 
transferred to another room”
1.2 Social isolation and exclusion In the process of interacting with others, some of the participants reported feeling excluded, often limiting their 
social activities
Participant 1: “I won’t go there next time if they treat me badly. During the chemotherapy a lot of hair has fallen out and I 
don’t feel well. I hardly go out”
Participant 11: “I feel I am isolated from the rest of the world”
Participant 13: “I feel I’m not as good as others because I have lung cancer. Sometimes I feel they exclude me”
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family, damage to self-image. An elaboration of these 
themes with supporting quotes can be found in Table 3.
Theme 2: experiences of stigma
Two kinds of experiences of stigma are perceived dis-
crimination, and social isolation and exclusion. An elabo-
ration of these themes with supporting quotes can be 
found in Table 4.
Theme 3: coping strategies
Study participants experiencing stigma primarily used 
four kinds of coping strategies including concealing the 
fact of sickness, seeking explanations to give to others, 
being cooperative patients, and disclosing dissatisfaction. 
An elaboration of these themes with supporting quotes 
can be found in Table 5.
Discussion
Sources of stigma
By organizing and analyzing the interview materials, the 
following four sources of Lung Cancer Stigma (LCS) were 
derived from the experiences of the participants: smok-
ing, decreased ability to work, difficulties caring for self 
and family, and damage to self-image.
Smoking increases the risk of lung cancer and is one of 
the most specific risk factors identified so far. Therefore, 
regardless of whether an individual’s particular lung can-
cer is caused by smoking, most people will believe that 
smoking is the cause. Cognitive psychology suggests that 
this leads to others having a poor impression of lung can-
cer patients. In addition, the participants in this study 
reported feeling extremely regretful, angry, or inferior 
as a result of ignoring their own health, refusing to give 
up smoking, or not paying attention to their health for a 
long period before developing lung cancer. These feelings 
often co-existed, causing a large amount of psychological 
interference and leading to decreased will to live, which 
is consistent with the findings of Bell and colleagues (Bell 
et al. 2010).
In terms of decreased ability to work, although the par-
ticipants reported receiving care from leaders and col-
leagues in the workplace, they felt that it was difficult to 
deliver on serious commitments, or that leaders would 
not delegate important, complicated, and particularly 
long-term work to them, resulting in a negative impact 
on their careers. This stigma of not being able to do their 
job can delay or prevent their return to work for a long 
time after their illness is treated.
In terms of the difficulties caring for self and family, 
many patients with lung cancer are middle-aged and are 
the mainstay of the family when healthy, supporting the 
elderly, raising children, and supplying money for fam-
ily spending. With a lung cancer diagnosis, middle-aged 
patients can lose their ability to supply money for the 
family, and may become unable to take care of their chil-
dren. Additionally, other family members have to spend a 
Table 5 Coping strategies
Themes Findings and supporting quotes
Concealing the fact of sickness Patients with lung cancer can suffer exclusion, rejection, and discrimination in their daily lives. In order to 
prevent such phenomena, patients reported concealing the fact of their sickness
Participant 8: “Some people mark me as ‘the source of infection’ after learning that I have lung cancer, which brings 
me a lot of trouble. So I know that I can’t tell others about my disease, and I ask my children not to tell others”
Participant 9: “I do not talk about my disease to others easily. If my superiors are aware of my disease, can I be 
promoted? I wish I could arrange work for my children before I retire. I undergo chemotherapy early in the morning 
and after chemotherapy I go back to work as quickly as possible, trying my best to hide the secret”
Seeking explanations to give to others During the interviews, several participants suggested that the main reason for alienation is that others are 
worried that the disease can be infectious. These participants reported studying the disease in detail by 
reading books and consulting doctors and nurses. They then explain the condition to others, and tell them 
that lung cancer is not contagious
Participant 2: “I repeated several times that the disease was not contagious. Don’t be afraid”
Being cooperative patients Because the source of LCS is related to a perception that patients themselves are responsible, those who want 
to reduce the stigma may try to be good, “cooperative” patients, following the treatment plan and actively 
caring for themselves, in hopes of an early hospital discharge and resumption of social and family roles
Participant 6: “I want to cure the disease quickly and leave the hospital soon”
Participant 9: “I cooperate with the doctors and nurses actively. I hope to get out of the hospital soon, so that I cause 
my children less trouble and reduce my feeling of guilt”
Disclosing dissatisfaction Patients can feel discontent and anger if their treatment results are not as they hoped, if they had high expec-
tations of recovery, or if they feel rejection and alienation from the outside world. These patients may not 
cooperate with treatment
Participant 10: “During that time I had a bad temper; I broke the thermos and cup, refused to receive nursing care, 
and was always angry with the medical staff”
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great deal of time caring for the patient. In line with this, 
patients might feel guilt toward their parents, spouses, 
and children, especially when accepting care from 
their families is perceived negatively along with limited 
resources due to paying high medical expenses. Feelings 
of shame can mean that some people are disappointed in 
themselves, which might even lead to despair and suicide. 
There have been a reports in recent years indicating that 
some patients with cancer commit suicide, based on the 
belief that, although they will not be able to continue to 
support their family, their death will provide some release 
from exhaustion and constraint for relatives, and that the 
family’s assets will be preserved (Villano et al. 2015).
As far as damage to self-image is concerned, chemo-
therapy and other lung cancer treatments can lead to 
hair loss and a deterioration in general appearance and 
manner, resulting in a sense of loss and self-abasement. 
Many patients with lung cancer have a cough and sputum 
production resulting in not only physical and psycho-
logical pain for patients, but also in feelings of inferior-
ity. Patients reported feeling that they’re “unclean” and 
they worry that they might be further loathed, excluded, 
alienated, or discriminated against by others. Debilitation 
following treatment often results in patients needing help 
with eating and going to the toilet. Many patients, espe-
cially those who value neatness and propriety, will thus 
feel a tremendous stigma with poor-self-image. Social 
isolation may result from avoidance and fear. The psycho-
logical pressure of lung cancer stigma can inhibit rebuild-
ing confidence and maintaining a good social mentality 
following treatment.
Experiences of stigma
Patients with lung cancer can experience perceived dis-
crimination, social isolation and exclusion from their 
colleagues, superiors, and even from friends. These expe-
riences may be based on ignorance of cancer itself such 
as concerns that the disease is contagious. Additionally, 
people associate cancer with death. Patients with lung 
cancer can thus be labeled as “a source of infection” and 
“death”. At the same time, patients perceive discrimi-
nation and rejection with resulting negative emotional 
reactions. The participants in the current study used 
expressions such as guilt, self-accusation, shame, anxiety, 
and self-abasement to describe their experiences. These 
negative emotional experiences can have long-term con-
sequences for patients, impairing their self-confidence, 
lowering their self-esteem, and leading to pessimism 
about the future (Chambers et al. 2012).
Coping strategies
According to the theory of stress response (Lazarus 
1993), we can divide LCS coping strategies into three 
categories. Stigma, as a negative psychological expe-
rience, involves three categories of coping responses: 
changing perceptions (emotion-focused coping) or 
changing behaviors (problem-focused coping), or a 
combination (mixed-focus coping). In order to avoid 
being labeled as a source of infection, or being rejected 
by others, patients with lung cancer may adopt mixed 
coping strategies to protect themselves. Link and col-
leagues (Link et al. 1989) historical work described how 
labeling can lead to negative outcomes and described 
several mixed-coping strategies that patients may adopt: 
(1) keeping the disease secret; (2) limiting participation 
in social activities; (3) trying to educate others; and (4) 
taking a stand against prejudice and discrimination. The 
participants in the current study documented coping 
strategies similar to those suggested by Link et al. (1989), 
thus continuing to support this historical perspective. 
Current study participants reduced emotional stress and 
psychological pressures by concealing the fact of sickness 
and limiting social activities, seeking information to edu-
cate others, and disclosing dissatisfaction with discrimi-
nation. Additionally they used strategies to reconstruct 
their self-image by being “cooperative” and adhering to 
treatment. These mixed-focus coping styles allowed them 
to change (cope with) their experience of stigma. Nev-
ertheless, concealing the fact of sickness and reducing 
social activities can have conflicting effects. While these 
coping strategies may decrease or eliminate avoidance or 
discrimination from others, there are problems. In order 
to conceal the condition, the patient has to receive treat-
ment and care in secret, which interrupts their daily rou-
tine and can interfere with receiving timely treatment. In 
addition, a patient who conceals the fact of sickness may 
not receive help from others. As a result, they may not 
obtain the rest necessary for coping with their illness, 
and can also face major psychological pressures and chal-
lenges. These patients can, in the long term, feel more 
lonely, afraid, and anxious than if they had disclosed their 
illness; consequently, they may experience increased 
helplessness and hopelessness (Chapple et al. 2004).
Suggestions for clinical nursing
To strengthen education of the public
Prejudice and discrimination from the public against 
patients with lung cancer result from a lack of knowl-
edge about the disease and misunderstanding of mul-
tiple causes of lung cancer. People may tend to believe 
that the disease is contagious and a sign of death. Medi-
cal staff should initiate public information campaigns by 
implementing lung cancer education programs in com-
munities and schools. For example, information can be 
found online at http://www.lung.org/assets/documents/
research/addressing-the-stigma-of-lung-cancer.pdf and 
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http://www.lungcancercanada.ca/Lung-Cancer/Stigma.
aspx. Nursing staff could also use mass media such as 
television, radio, and the internet; print media such as 
books and leaflets; and audiovisual tools such as films, 
and other media to provide accurate and factual informa-
tion specifically about lung cancer to reduce the stigma. 
Such measures will help the public to acquire knowl-
edge, correct misunderstandings about lung cancer, and 
improve the social environment for patients with lung 
cancer.
Reduce feelings of stigma by using cognitive therapy
Cognitive therapy is effective in treating anxiety, depres-
sion, and self-denial (Li 2011). Medical staff can apply 
cognitive therapy to help patients with lung cancer to 
identify and modify negative knowledge and beliefs, 
develop a positive attitude toward the disease, and 
gradually adjust to normal life. Nursing staff should first 
actively guide and educate patients to acknowledge and 
accept themselves. Next, nursing staff can help patients 
with lung cancer to enhance their self-confidence and 
self-esteem by identifying their inner strengths and 
potential in combating the disease, as well as positive 
events and experiences in their lives. Nurses can help 
patients to develop interpersonal skills and adapt ability, 
improved communication skills, and build resilience and 
an approach to disclose dissatisfaction in dealing with 
stigma.
Enhance social support
Lack of social support as a negative impact on the prog-
nosis of disease, and serious effects on physical and men-
tal health. Medical staff should help patients to establish 
effective social support networks, build a positive inter-
personal communication environment, and improve 
their degree of social support. Communicating with 
patients can be an effective measure to reduce the experi-
ence of stigma (Li 2011). By supportive communication 
with patients, and awareness of their psychological state, 
feelings of fear and discrimination can be decreased. This 
can also help patients return to their families and work-
places, and be part of their community. Many resources 
can be found and used by nurses to educate and advocate 
for patients. For example, https://www.iaslc.org/patient-
resources/advocacy-partners is a website that could be 
provided to government agencies, social groups, and 
community agencies to help the public develop a positive 
and caring attitude toward patients with lung cancer. It 
remains critical to help people to quit smoking, however, 
clinical and educational approaches should be offered 
with care so as not to increase the stigma experienced by 
patients with lung cancer.
Limitations
This study has a number of limitations. The age range of 
the participants is 29–80 years, which is atypical for lung 
cancer. A younger individual with lung cancer may expe-
rience stigma very differently than an older individual 
and this is an atypical wide range in age of the sample. 
This may limit the generalizability of our results. Sec-
ond, all patients who participated in the research were 
recruited from the same hospital in China. It might be 
that lung cancer patients who come from other treat-
ment centers have different experiences. Third, the data 
were collected with participants in hospitals; there is a 
need for longitudinal research into whether a lung cancer 
patient’s experiences will change over longer periods of 
time after hospital discharge, as well as studies of “coping 
with stigma” with lung cancer patients in the outpatient 
setting.
Implications for nursing and health policy
As point-of-care providers, staff nurses are well posi-
tioned to develop effective interventions to help patients 
deal with stigma and to accomplish the goal of providing 
holistic care.
Conclusions
Results from this qualitative study indicate that patients 
with lung cancer in China experience multiple sources 
of stigma, and have experiences that can be categories 
as discrimination, social isolation and exclusion. This 
study adds to our understanding of the coping strategies 
that patients with lung cancer use to deal with stigma. As 
point-of-care providers, staff nurses are well positioned 
to develop effective interventions to help patients deal 
with stigma and to accomplish the goal of providing non-
prejudicial nursing care.
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